COMMUNIQUÉS West-GlobeNewswire

Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
18/09/2026
FORT LAUDERDALE, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) today announced that it has entered into definitive agreements with institutional investors in a registered direct [...]
Aspen Neuroscience Announces Publication of Sasineprocel Preclinical Data in "Cell Stem Cell"
18/09/2026
Peer-reviewed findings describe reproducible manufacturing, leading-edge genomic quality controls and preclinical evidence supporting clinical development of an autologous iPSC-derived neuron replacement therapy for [...]
Hydration Room Expands Beyond California Opening First Clinic in Texas
18/09/2026
Physician-Founded Clinic Brings Medically-Guided IV and Injection Therapy to Texas IRVINE, CA and DALLAS, TX, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Hydration Room , the physician-founded wellness company known for its [...]
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
18/09/2026
If approved, Cosentyx (secukinumab) will be first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica (PMR), providing new treatment option after steroids¹ Recommendation based on data showing Cos [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share
18/09/2026
SAN JUAN CAPISTRANO, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
18/09/2026
Press release – No. 16 / 2026 Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome The CHMP of the European Medicines Agency has recommended the approval [...]
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
18/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has entered into a partnership with QIMA Life Sciences, a [...]
Novo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)
18/09/2026
If approved, Sogroya® (somapacitan) would be the first and only growth hormone treatment approved for idiopathic short stature in the EU, providing a much-needed treatment option for children and their families affected [...]
CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis
18/09/2026
Ocrevus addresses a critical need in paediatric neurology as the first high- efficacy anti-CD20 treatment option for people with MS as young as 10 years old In the Phase III OPERETTA 2 study, Ocrevus demonstrated non- [...]
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
18/09/2026
POMPANO BEACH, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and [...]
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
18/09/2026
Strengthened balance sheet with successful completion of upsized $168.3 million initial public offering Announced FDA Fast Track designation for BH-30643 for the treatment of advanced EGFR C797S-positive NSCLC SAN DIEGO [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/09/2026
BEDFORD, Mass., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
CHMP recommends approval of Johnson & Johnson’s TECVAYLI®▼ (teclistamab) in relapsed/refractory multiple myeloma after at least one prior therapy
18/09/2026
CHMP recommendation follows positive Phase 3 study results, marking the second Phase 3 study to demonstrate benefit with a TECVAYLI ® -based regimen in the second-line setting 1 ,2 Results demonstrated significantly [...]
Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
18/09/2026
- FDA approval represents a monumental milestone for patients with MPS IIIA and validates Abeona’s foundational R&D and clinical development efforts - - Ultragenyx successfully brought a life-changing therapy across [...]
Ipsen nomme Mariette Finet administratrice au sein de son Conseil d’administration
18/09/2026
Ipsen nomme Mariette Finet administratrice au sein de son Conseil d’administration PARIS, FRANCE, 18 SEPTEMBRE 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd’hui la cooptation de Mariette Finet en qualité d’ [...]
Ipsen appoints Mariette Finet to its Board of Directors
18/09/2026
Ipsen appoints Mariette Finet to its Board of Directors PARIS, FRANCE, 18 SEPTEMBER 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Mariette Finet as a Director to its Board of Directors, [...]
DXS INTERNATIONAL PLC (AQSE: DXSP): Timing of FY Results to 30 April 2026
18/09/2026
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union ( [...]
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
18/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of [...]
Immumax Expands Global Access to the E-Tapper to Empower Natural Health Management from Home
18/09/2026
HONG KONG, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Immumax, a pioneer in alternative health and wellness solutions, has announced the international expansion of its online training and consultation services. Focused on [...]

Pages